neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 5.715

+5.6%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rich Genik who wrote (2)	8/23/1997 10:42:00 PM
From: Kramer	of 441

In todays Barrons featured research reports -- NEOG a Strong Buy! by First of Michigan (7 7/8, July 29) Strong Buy. We believe Neogen to be well-positioned to capitalize on a rapidly growing industry that could reach $500 million by the year 2000. With food safety being one of the leading public concerns and Congress continuing its dicussions for additional mandated testing requirements, the likelihood of any slowing in the near term is minimal. Today, the market for the company's products is largely unpenetrated. Neogen has the largest market share, with approximately 3% of the total market for biotechnology-based diagnostics, while its competitors combine for an additional 11% of the market. The remaining 86% provides enormous growth opportunities.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next